Ricardo Salgado‐Aranda

952 total citations
27 papers, 194 citations indexed

About

Ricardo Salgado‐Aranda is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Neurology. According to data from OpenAlex, Ricardo Salgado‐Aranda has authored 27 papers receiving a total of 194 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 5 papers in Surgery and 2 papers in Neurology. Recurrent topics in Ricardo Salgado‐Aranda's work include Cardiac Arrhythmias and Treatments (15 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Cardiac pacing and defibrillation studies (10 papers). Ricardo Salgado‐Aranda is often cited by papers focused on Cardiac Arrhythmias and Treatments (15 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Cardiac pacing and defibrillation studies (10 papers). Ricardo Salgado‐Aranda collaborates with scholars based in Spain, Sweden and Canada. Ricardo Salgado‐Aranda's co-authors include Nicasio Pérez‐Castellano, Julián Pérez‐Villacastín, Adolfo Fontenla, Juan José González‐Ferrer, Victoria Cañadas‐Godoy, David Filgueiras‐Rama, María López‐Gil, Fernando Arribas, F. Fernandez and Lin Wang and has published in prestigious journals such as Journal of the American Heart Association, Heart Rhythm and Journal of Cardiovascular Electrophysiology.

In The Last Decade

Ricardo Salgado‐Aranda

23 papers receiving 187 citations

Peers

Ricardo Salgado‐Aranda
Jan Přeček Czechia
Nduka C. Okwose United Kingdom
Tariq Nisar United States
Sam Harris Australia
Jan Přeček Czechia
Ricardo Salgado‐Aranda
Citations per year, relative to Ricardo Salgado‐Aranda Ricardo Salgado‐Aranda (= 1×) peers Jan Přeček

Countries citing papers authored by Ricardo Salgado‐Aranda

Since Specialization
Citations

This map shows the geographic impact of Ricardo Salgado‐Aranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricardo Salgado‐Aranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricardo Salgado‐Aranda more than expected).

Fields of papers citing papers by Ricardo Salgado‐Aranda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ricardo Salgado‐Aranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricardo Salgado‐Aranda. The network helps show where Ricardo Salgado‐Aranda may publish in the future.

Co-authorship network of co-authors of Ricardo Salgado‐Aranda

This figure shows the co-authorship network connecting the top 25 collaborators of Ricardo Salgado‐Aranda. A scholar is included among the top collaborators of Ricardo Salgado‐Aranda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ricardo Salgado‐Aranda. Ricardo Salgado‐Aranda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Quintanilla, Jorge G., David Calvo, Javier Sánchez‐Gonzalez, et al.. (2024). Dispersion of Activation in Single‐Beat Global Maps During Programmed Ventricular Stimulation Identifies Infarct‐Related Ventricular Tachycardia Isthmus Sites. Journal of the American Heart Association. 13(23). e038441–e038441.
2.
Fontenla, Adolfo, Juan Tamargo, Ricardo Salgado‐Aranda, et al.. (2023). Ivabradine for controlling heart rate in permanent atrial fibrillation: A translational clinical trial. Heart Rhythm. 20(6). 822–830. 13 indexed citations
3.
Salgado‐Aranda, Ricardo, et al.. (2022). A Differential Profile of Biomarkers between Patients with Atrial Fibrillation and Healthy Controls. Journal of Personalized Medicine. 12(9). 1406–1406. 3 indexed citations
4.
Salgado‐Aranda, Ricardo, et al.. (2021). sST2 and Galectin-3 genotyping in patients with persistent atrial fibrillation. Molecular Biology Reports. 48(2). 1601–1606. 5 indexed citations
5.
Salgado‐Aranda, Ricardo, Nicasio Pérez‐Castellano, Iván J. Núñez‐Gil, et al.. (2021). Influence of Baseline Physical Activity as a Modifying Factor on COVID-19 Mortality: A Single-Center, Retrospective Study. Infectious Diseases and Therapy. 10(2). 801–814. 56 indexed citations
6.
Salgado‐Aranda, Ricardo, et al.. (2020). Impact of the first wave of the SARS-CoV-2 pandemic on preferential/emergent pacemaker implantation rate. Spanish study. Revista Española de Cardiología (English Edition). 74(5). 469–472. 9 indexed citations
7.
Salgado‐Aranda, Ricardo, et al.. (2020). Biomarkers in atrial fibrillation and heart failure with non-reduced ejection fraction: Diagnostic application and new cut-off points. Heart & Lung. 49(4). 388–392. 9 indexed citations
8.
Salgado‐Aranda, Ricardo, et al.. (2020). Impacto de la primera ola de la pandemia de SARS-CoV-2 en la tasa de implante de marcapasos con indicación preferente/urgente. Estudio español. Revista Española de Cardiología. 74(5). 469–472. 9 indexed citations
9.
Fontenla, Adolfo, María López‐Gil, Ricardo Salgado‐Aranda, et al.. (2019). Ivabradine for chronic heart rate control in persistent atrial fibrillation. Design of the BRAKE-AF project. Revista Española de Cardiología (English Edition). 73(5). 368–375. 11 indexed citations
11.
Loughlin, Gerard, Tomás Datino, F. Fernandez, et al.. (2016). Immediate post-procedure bridging with unfractioned heparin versus low molecular weight heparin in patients undergoing radiofrequency ablation for atrial fibrillation with an interrupted oral anticoagulation strategy. Journal of Interventional Cardiac Electrophysiology. 45(2). 149–158. 1 indexed citations
13.
Salgado‐Aranda, Ricardo, et al.. (2016). Small‐Caliber Lead Failure After Generator Exchange. Journal of Cardiovascular Electrophysiology. 27(7). 846–850. 2 indexed citations
14.
Åkerström, Finn, Marta Pachón, Alberto Puchol, et al.. (2015). Performance of the SA‐VA Difference to Differentiate Atrioventricular Nodal Reentrant Tachycardia from Orthodromic Reentrant Tachycardia in a Large Cohort of Consecutive Patients. Pacing and Clinical Electrophysiology. 38(9). 1066–1072. 2 indexed citations
15.
Åkerström, Finn, Marta Pachón, Alberto Puchol, et al.. (2015). Number of Beats in the Transition Zone With Fixed SA Interval during Right Ventricular Overdrive Pacing Determines Accessory Pathway Location in Orthodromic Reentrant Tachycardia. Pacing and Clinical Electrophysiology. 39(1). 21–27. 1 indexed citations
16.
López‐Gil, María, et al.. (2013). Utilidad de la ergometría convencional en el seguimiento de pacientes portadores de dispositivos de resincronización cardiaca. Revista Española de Cardiología. 66(11). 912–913. 3 indexed citations
17.
López‐Gil, María, Ricardo Salgado‐Aranda, José Luís Merino, et al.. (2013). Cavo-tricuspid isthmus radiofrequency ablation using a novel remote navigation catheter system in patients with typical atrial flutter. EP Europace. 16(4). 558–562. 14 indexed citations
18.
Fontenla, Adolfo, José Antonio García‐Donaire, Felipe Hernández, et al.. (2012). Management of Resistant Hypertension in a Multidisciplinary Unit of Renal Denervation: Protocol and Results. Revista Española de Cardiología (English Edition). 66(5). 364–370. 1 indexed citations
19.
Fontenla, Adolfo, Ricardo Salgado‐Aranda, & Fernando Arribas. (2012). An electrocardiographic proof of substrate modification during ablation of tetralogy of Fallot associated right ventricular tachycardia. EP Europace. 14(10). 1474–1474. 1 indexed citations
20.
Montero-Cabezas, José M., et al.. (2012). 1:1 Atrial Flutter After Vernakalant Administration for Atrial Fibrillation Cardioversion. Revista Española de Cardiología (English Edition). 65(11). 1062–1064. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026